Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-12-05
1996-04-02
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 19, 530328, 530329, A61K 3800, C07K 506, C07K 706, C07K 700
Patent
active
055040705
ABSTRACT:
Novel and known compounds are described which inhibit endothelin converting enzyme (ECE), thereby preventing the conversion of Big Endothelin (BET) to Endothelin (ET). Pharmaceutical usefulness and preparations are described.
REFERENCES:
patent: 4452790 (1984-06-01), Karanewsky
patent: 4610816 (1986-09-01), Berger
patent: 4918105 (1990-04-01), Cartwright
Bihovsky Ron H.
Erhardt Paul W.
Lampe John W.
Mohan Raju
Shaw Kenneth J.
Bellamy Elizabeth A.
Berlex Laboratories Inc.
Hamlet-King Diana
Lebovitz Richard M.
Marshall S. G.
LandOfFree
Inhibitors of the conversion of big endothelin to endothelin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of the conversion of big endothelin to endothelin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of the conversion of big endothelin to endothelin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2016366